Tapewire

Nasdaq · USD

IRON

Disc Medicine, Inc.

Export transactions ↓
Tapewire entity
2273
SEC CIK
0001816736
Parsed reports
281

Last 12 months

Inside the activity.

0 purchase rows · 91 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 2025029
Jan 202604
Feb 202609
Mar 202602
Apr 202604
May 202600
Jun 2026012
Jul 202604
Aug 202607
Sep 2026016
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 15, 2026 Filed Sep 16, 2026 22:44 UTC
Quisel John DDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 36,000 $0.00 Strike: $1.01 $0.00
Disclosure

SEC source: 0001193125-26-393353 · ownership.xml · derivative · entry 2

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,120

Underlying: Common Stock · 36,000 shares

Expires 2030-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
September 15, 2026 Filed Sep 16, 2026 22:44 UTC
Quisel John DDirector · Chief Executive Officer
Exercise / conversionCommon Stock 36,000 $1.01 $36,360.00
Disclosure

SEC source: 0001193125-26-393353 · ownership.xml · nonDerivative · entry 1

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262,064

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 11, 2026 Filed Sep 15, 2026 20:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $50.86 $0.00
Disclosure

SEC source: 0001591747-26-000007 · form4-09152026_040930.xml · derivative · entry 10

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2035-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Fully vested and exercisable.

Read SEC document
September 11, 2026 Filed Sep 15, 2026 20:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $38.85 $0.00
Disclosure

SEC source: 0001591747-26-000007 · form4-09152026_040930.xml · derivative · entry 9

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2034-06-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Fully vested and exercisable.

Read SEC document
September 11, 2026 Filed Sep 15, 2026 20:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,136 $0.00 Strike: $45.69 $0.00
Disclosure

SEC source: 0001591747-26-000007 · form4-09152026_040930.xml · derivative · entry 8

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,136 shares

Expires 2033-06-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Fully vested and exercisable.

Read SEC document
September 11, 2026 Filed Sep 15, 2026 20:30 UTC SaleCommon Stock 27,136 $70.11 $1,902,504.96
Disclosure

SEC source: 0001591747-26-000007 · form4-09152026_040930.xml · nonDerivative · entry 4

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.10 to $70.37 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 11, 2026 Filed Sep 15, 2026 20:30 UTC Exercise / conversionCommon Stock 10,000 $50.86 $508,600.00
Disclosure

SEC source: 0001591747-26-000007 · form4-09152026_040930.xml · nonDerivative · entry 3

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,136

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 11, 2026 Filed Sep 15, 2026 20:30 UTC Exercise / conversionCommon Stock 10,000 $38.85 $388,500.00
Disclosure

SEC source: 0001591747-26-000007 · form4-09152026_040930.xml · nonDerivative · entry 2

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,136

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 11, 2026 Filed Sep 15, 2026 20:30 UTC Exercise / conversionCommon Stock 7,136 $45.69 $326,043.84
Disclosure

SEC source: 0001591747-26-000007 · form4-09152026_040930.xml · nonDerivative · entry 1

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,136

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 04, 2026 Filed Sep 9, 2026 20:23 UTC SaleCommon Stock 18 $79.96 $1,439.28
Disclosure

SEC source: 0001591747-26-000005 · form4-09092026_080927.xml · nonDerivative · entry 3

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 13,427

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.95 to $79.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 · ownership.nature: These shares are held by Atlas Venture Fund XII, L.P. ("Atlas XII"). The general partner of Atlas XII is Atlas Venture Associates XII, L.P. ("Associates XII"). Atlas Venture Associates XII, LLC ("Associates XII LLC") is the general partner of Associates XII. The Reporting Person is a member of Associates XII LLC and disclaims beneficial ownership of such securities held by Atlas XII, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 04, 2026 Filed Sep 9, 2026 20:23 UTC SaleCommon Stock 759 $79.96 $60,689.64
Disclosure

SEC source: 0001591747-26-000005 · form4-09092026_080927.xml · nonDerivative · entry 2

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 312,230

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.95 to $79.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · ownership.nature: These shares are held by Atlas Venture Opportunity Fund II, L.P. ("Opportunity II"). The general partner of Opportunity II is Atlas Venture Associates Opportunity II, L.P. ("Associates II"). Atlas Venture Associates Opportunity II, LLC ("Associates II LLC") is the general partner of Associates II. The Reporting Person is a member of Associates II LLC and disclaims beneficial ownership of such securities held by Opportunity II, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 04, 2026 Filed Sep 9, 2026 20:23 UTC SaleCommon Stock 912 $79.96 $72,923.52
Disclosure

SEC source: 0001591747-26-000005 · form4-09092026_080927.xml · nonDerivative · entry 1

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 318,866

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.95 to $79.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: These shares are held by Atlas Venture Opportunity Fund I, L.P. ("Opportunity I"). The general partner of Opportunity I is Atlas Venture Associates Opportunity I, L.P. ("Associates I"). Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. The Reporting Person is a member of Associates I LLC and disclaims beneficial ownership of such securities held by Opportunity I, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 03, 2026 Filed Sep 3, 2026 21:43 UTC SaleCommon Stock 54 $79.98 $4,318.92
Disclosure

SEC source: 0001591747-26-000002 · form4-09032026_090939.xml · nonDerivative · entry 12

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 13,445

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.95 to $80.28 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · ownership.nature: These shares are held by Atlas Venture Fund XII, L.P. ("Atlas XII"). The general partner of Atlas XII is Atlas Venture Associates XII, L.P. ("Associates XII"). Atlas Venture Associates XII, LLC ("Associates XII LLC") is the general partner of Associates XII. The Reporting Person is a member of Associates XII LLC and disclaims beneficial ownership of such securities held by Atlas XII, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 03, 2026 Filed Sep 3, 2026 21:43 UTC SaleCommon Stock 2,339 $79.98 $187,073.22
Disclosure

SEC source: 0001591747-26-000002 · form4-09032026_090939.xml · nonDerivative · entry 11

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 312,989

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.95 to $80.28 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: These shares are held by Atlas Venture Opportunity Fund II, L.P. ("Opportunity II"). The general partner of Opportunity II is Atlas Venture Associates Opportunity II, L.P. ("Associates II"). Atlas Venture Associates Opportunity II, LLC ("Associates II LLC") is the general partner of Associates II. The Reporting Person is a member of Associates II LLC and disclaims beneficial ownership of such securities held by Opportunity II, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 03, 2026 Filed Sep 3, 2026 21:43 UTC SaleCommon Stock 2,810 $79.98 $224,743.80
Disclosure

SEC source: 0001591747-26-000002 · form4-09032026_090939.xml · nonDerivative · entry 10

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 319,778

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.95 to $80.28 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These shares are held by Atlas Venture Opportunity Fund I, L.P. ("Opportunity I"). The general partner of Opportunity I is Atlas Venture Associates Opportunity I, L.P. ("Associates I"). Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. The Reporting Person is a member of Associates I LLC and disclaims beneficial ownership of such securities held by Opportunity I, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 02, 2026 Filed Sep 3, 2026 21:43 UTC SaleCommon Stock 2 $80.98 $161.96
Disclosure

SEC source: 0001591747-26-000002 · form4-09032026_090939.xml · nonDerivative · entry 9

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 13,499

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.9677 to $81.0079 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · ownership.nature: These shares are held by Atlas Venture Fund XII, L.P. ("Atlas XII"). The general partner of Atlas XII is Atlas Venture Associates XII, L.P. ("Associates XII"). Atlas Venture Associates XII, LLC ("Associates XII LLC") is the general partner of Associates XII. The Reporting Person is a member of Associates XII LLC and disclaims beneficial ownership of such securities held by Atlas XII, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 02, 2026 Filed Sep 3, 2026 21:43 UTC SaleCommon Stock 9 $80.98 $728.82
Disclosure

SEC source: 0001591747-26-000002 · form4-09032026_090939.xml · nonDerivative · entry 8

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 315,328

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.9677 to $81.0079 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: These shares are held by Atlas Venture Opportunity Fund II, L.P. ("Opportunity II"). The general partner of Opportunity II is Atlas Venture Associates Opportunity II, L.P. ("Associates II"). Atlas Venture Associates Opportunity II, LLC ("Associates II LLC") is the general partner of Associates II. The Reporting Person is a member of Associates II LLC and disclaims beneficial ownership of such securities held by Opportunity II, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 02, 2026 Filed Sep 3, 2026 21:43 UTC SaleCommon Stock 10 $80.98 $809.80
Disclosure

SEC source: 0001591747-26-000002 · form4-09032026_090939.xml · nonDerivative · entry 7

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 322,588

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.9677 to $81.0079 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These shares are held by Atlas Venture Opportunity Fund I, L.P. ("Opportunity I"). The general partner of Opportunity I is Atlas Venture Associates Opportunity I, L.P. ("Associates I"). Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. The Reporting Person is a member of Associates I LLC and disclaims beneficial ownership of such securities held by Opportunity I, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 02, 2026 Filed Sep 3, 2026 21:43 UTC SaleCommon Stock 511 $80.17 $40,966.87
Disclosure

SEC source: 0001591747-26-000002 · form4-09032026_090939.xml · nonDerivative · entry 6

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 13,501

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.95 to $80.9421 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · ownership.nature: These shares are held by Atlas Venture Fund XII, L.P. ("Atlas XII"). The general partner of Atlas XII is Atlas Venture Associates XII, L.P. ("Associates XII"). Atlas Venture Associates XII, LLC ("Associates XII LLC") is the general partner of Associates XII. The Reporting Person is a member of Associates XII LLC and disclaims beneficial ownership of such securities held by Atlas XII, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 02, 2026 Filed Sep 3, 2026 21:43 UTC SaleCommon Stock 22,090 $80.17 $1,770,955.30
Disclosure

SEC source: 0001591747-26-000002 · form4-09032026_090939.xml · nonDerivative · entry 5

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 315,337

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.95 to $80.9421 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: These shares are held by Atlas Venture Opportunity Fund II, L.P. ("Opportunity II"). The general partner of Opportunity II is Atlas Venture Associates Opportunity II, L.P. ("Associates II"). Atlas Venture Associates Opportunity II, LLC ("Associates II LLC") is the general partner of Associates II. The Reporting Person is a member of Associates II LLC and disclaims beneficial ownership of such securities held by Opportunity II, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 02, 2026 Filed Sep 3, 2026 21:43 UTC SaleCommon Stock 26,542 $80.17 $2,127,872.14
Disclosure

SEC source: 0001591747-26-000002 · form4-09032026_090939.xml · nonDerivative · entry 4

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 322,598

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.95 to $80.9421 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These shares are held by Atlas Venture Opportunity Fund I, L.P. ("Opportunity I"). The general partner of Opportunity I is Atlas Venture Associates Opportunity I, L.P. ("Associates I"). Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. The Reporting Person is a member of Associates I LLC and disclaims beneficial ownership of such securities held by Opportunity I, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 21:43 UTC SaleCommon Stock 1 $79.95 $79.95
Disclosure

SEC source: 0001591747-26-000002 · form4-09032026_090939.xml · nonDerivative · entry 3

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 14,012

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F4 · ownership.nature: These shares are held by Atlas Venture Fund XII, L.P. ("Atlas XII"). The general partner of Atlas XII is Atlas Venture Associates XII, L.P. ("Associates XII"). Atlas Venture Associates XII, LLC ("Associates XII LLC") is the general partner of Associates XII. The Reporting Person is a member of Associates XII LLC and disclaims beneficial ownership of such securities held by Atlas XII, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 21:43 UTC SaleCommon Stock 58 $79.95 $4,637.10
Disclosure

SEC source: 0001591747-26-000002 · form4-09032026_090939.xml · nonDerivative · entry 2

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 337,427

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F3 · ownership.nature: These shares are held by Atlas Venture Opportunity Fund II, L.P. ("Opportunity II"). The general partner of Opportunity II is Atlas Venture Associates Opportunity II, L.P. ("Associates II"). Atlas Venture Associates Opportunity II, LLC ("Associates II LLC") is the general partner of Associates II. The Reporting Person is a member of Associates II LLC and disclaims beneficial ownership of such securities held by Opportunity II, except to the extent of his pecuniary interest therein, if any.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 21:43 UTC SaleCommon Stock 70 $79.95 $5,596.50
Disclosure

SEC source: 0001591747-26-000002 · form4-09032026_090939.xml · nonDerivative · entry 1

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 349,140

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

F2 · ownership.nature: These shares are held by Atlas Venture Opportunity Fund I, L.P. ("Opportunity I"). The general partner of Opportunity I is Atlas Venture Associates Opportunity I, L.P. ("Associates I"). Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. The Reporting Person is a member of Associates I LLC and disclaims beneficial ownership of such securities held by Opportunity I, except to the extent of his pecuniary interest therein, if any.

Read SEC document
August 25, 2026 Filed Aug 27, 2026 00:10 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 8,796 $0.00 Strike: $13.50 $0.00
Disclosure

SEC source: 0001193125-26-369179 · ownership.xml · derivative · entry 6

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,847

Underlying: Common Stock · 8,796 shares

Expires 2032-12-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

F4 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
August 25, 2026 Filed Aug 27, 2026 00:10 UTC
Yu Jonathan Yen-WenChief Operating Officer
SaleCommon Stock 8,796 $83.12 $731,091.85
Disclosure

SEC source: 0001193125-26-369179 · ownership.xml · nonDerivative · entry 4

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,324

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.57 to $83.47, inclusive.

Read SEC document
August 25, 2026 Filed Aug 27, 2026 00:10 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionCommon Stock 8,796 $13.50 $118,746.00
Disclosure

SEC source: 0001193125-26-369179 · ownership.xml · nonDerivative · entry 3

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,120

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

Read SEC document
August 24, 2026 Filed Aug 27, 2026 00:10 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 300 $0.00 Strike: $13.50 $0.00
Disclosure

SEC source: 0001193125-26-369179 · ownership.xml · derivative · entry 5

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,643

Underlying: Common Stock · 300 shares

Expires 2032-12-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

F4 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
August 24, 2026 Filed Aug 27, 2026 00:10 UTC
Yu Jonathan Yen-WenChief Operating Officer
SaleCommon Stock 300 $82.53 $24,759.99
Disclosure

SEC source: 0001193125-26-369179 · ownership.xml · nonDerivative · entry 2

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,324

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.50 to $82.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
August 24, 2026 Filed Aug 27, 2026 00:10 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionCommon Stock 300 $13.50 $4,050.00
Disclosure

SEC source: 0001193125-26-369179 · ownership.xml · nonDerivative · entry 1

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,624

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

Read SEC document
August 17, 2026 Filed Aug 18, 2026 22:56 UTC
Quisel John DDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 33,000 $0.00 Strike: $13.50 $0.00
Disclosure

SEC source: 0001193125-26-355841 · ownership.xml · derivative · entry 5

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 91,586

Underlying: Common Stock · 33,000 shares

Expires 2032-12-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

F5 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
August 17, 2026 Filed Aug 18, 2026 22:56 UTC
Quisel John DDirector · Chief Executive Officer
SaleCommon Stock 11,888 $79.84 $949,161.70
Disclosure

SEC source: 0001193125-26-355841 · ownership.xml · nonDerivative · entry 4

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 226,064

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.53 to $80.02, inclusive.

Read SEC document
August 17, 2026 Filed Aug 18, 2026 22:56 UTC
Quisel John DDirector · Chief Executive Officer
SaleCommon Stock 12,712 $79.20 $1,006,729.38
Disclosure

SEC source: 0001193125-26-355841 · ownership.xml · nonDerivative · entry 3

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 237,952

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.53 to $79.52, inclusive.

Read SEC document
August 17, 2026 Filed Aug 18, 2026 22:56 UTC
Quisel John DDirector · Chief Executive Officer
SaleCommon Stock 8,400 $78.11 $656,091.24
Disclosure

SEC source: 0001193125-26-355841 · ownership.xml · nonDerivative · entry 2

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 250,664

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.50 to $78.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

Read SEC document
August 17, 2026 Filed Aug 18, 2026 22:56 UTC
Quisel John DDirector · Chief Executive Officer
Exercise / conversionCommon Stock 33,000 $13.50 $445,500.00
Disclosure

SEC source: 0001193125-26-355841 · ownership.xml · nonDerivative · entry 1

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 259,064

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 23:14 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 804 $0.00 Strike: $13.50 $0.00
Disclosure

SEC source: 0001193125-26-352823 · ownership.xml · derivative · entry 3

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,943

Underlying: Common Stock · 804 shares

Expires 2032-12-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

F3 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 23:14 UTC
Yu Jonathan Yen-WenChief Operating Officer
SaleCommon Stock 804 $82.64 $66,444.57
Disclosure

SEC source: 0001193125-26-352823 · ownership.xml · nonDerivative · entry 2

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,324

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.54 to $82.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
August 12, 2026 Filed Aug 14, 2026 23:14 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionCommon Stock 804 $13.50 $10,854.00
Disclosure

SEC source: 0001193125-26-352823 · ownership.xml · nonDerivative · entry 1

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,128

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

Read SEC document
August 06, 2026 Filed Aug 7, 2026 21:32 UTC
Khara RahulChief Legal Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $14.69 $0.00
Disclosure

SEC source: 0001193125-26-340543 · ownership.xml · derivative · entry 3

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,804

Underlying: Common Stock · 5,000 shares

Expires 2032-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

F3 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
August 06, 2026 Filed Aug 7, 2026 21:32 UTC
Khara RahulChief Legal Officer
SaleCommon Stock 5,000 $80.00 $400,000.00
Disclosure

SEC source: 0001193125-26-340543 · ownership.xml · nonDerivative · entry 2

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,324

F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

F2 · balance_after: Includes 151 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2026.

Read SEC document
August 06, 2026 Filed Aug 7, 2026 21:32 UTC
Khara RahulChief Legal Officer
Exercise / conversionCommon Stock 5,000 $14.69 $73,450.00
Disclosure

SEC source: 0001193125-26-340543 · ownership.xml · nonDerivative · entry 1

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,324

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

F2 · balance_after: Includes 151 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2026.

Read SEC document
July 13, 2026 Filed Jul 14, 2026 22:32 UTC
Quisel John DDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 7,416 $0.00 Strike: $13.50 $0.00
Disclosure

SEC source: 0001193125-26-303535 · ownership.xml · derivative · entry 7

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,586

Underlying: Common Stock · 7,416 shares

Expires 2032-12-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

F6 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 13, 2026 Filed Jul 14, 2026 22:32 UTC
Quisel John DDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,584 $0.00 Strike: $9.86 $0.00
Disclosure

SEC source: 0001193125-26-303535 · ownership.xml · derivative · entry 6

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,791

Underlying: Common Stock · 25,584 shares

Expires 2031-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

F5 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 13, 2026 Filed Jul 14, 2026 22:32 UTC
Quisel John DDirector · Chief Executive Officer
SaleCommon Stock 6,400 $76.05 $486,732.80
Disclosure

SEC source: 0001193125-26-303535 · ownership.xml · nonDerivative · entry 5

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 226,064

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.83 to $76.29, inclusive.

Read SEC document
July 13, 2026 Filed Jul 14, 2026 22:32 UTC
Quisel John DDirector · Chief Executive Officer
SaleCommon Stock 16,896 $74.95 $1,266,302.82
Disclosure

SEC source: 0001193125-26-303535 · ownership.xml · nonDerivative · entry 4

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 232,464

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.62 to $75.50, inclusive.

Read SEC document
July 13, 2026 Filed Jul 14, 2026 22:32 UTC
Quisel John DDirector · Chief Executive Officer
SaleCommon Stock 9,704 $74.27 $720,744.22
Disclosure

SEC source: 0001193125-26-303535 · ownership.xml · nonDerivative · entry 3

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 249,360

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.62 to $74.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

Read SEC document
July 13, 2026 Filed Jul 14, 2026 22:32 UTC
Quisel John DDirector · Chief Executive Officer
Exercise / conversionCommon Stock 7,416 $13.50 $100,116.00
Disclosure

SEC source: 0001193125-26-303535 · ownership.xml · nonDerivative · entry 2

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 259,064

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

Read SEC document
July 13, 2026 Filed Jul 14, 2026 22:32 UTC
Quisel John DDirector · Chief Executive Officer
Exercise / conversionCommon Stock 25,584 $9.86 $252,258.24
Disclosure

SEC source: 0001193125-26-303535 · ownership.xml · nonDerivative · entry 1

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 251,648

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

Read SEC document
July 07, 2026 Filed Jul 9, 2026 23:35 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 100 $0.00 Strike: $13.50 $0.00
Disclosure

SEC source: 0001193125-26-299954 · ownership.xml · derivative · entry 3

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,747

Underlying: Common Stock · 100 shares

Expires 2032-12-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

F2 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 07, 2026 Filed Jul 9, 2026 23:35 UTC
Yu Jonathan Yen-WenChief Operating Officer
SaleCommon Stock 100 $82.50 $8,250.00
Disclosure

SEC source: 0001193125-26-299954 · ownership.xml · nonDerivative · entry 2

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,324

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.